Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pulmonx CorpLUNG · Entity 2359 | INTERIM CFO | March 01, 2024 | March 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pulmonx Corp
Report date March 01, 2024 · Filed March 08, 2024 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,210 |
Reported balance
After 2024-03-01 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2024-03-01 · Grant · Acquired 28,800 · Balance 76,210 F1: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.30 · Expires 2034-02-28 | Direct | 14,400 |
Reported balance
After 2024-03-01 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2024-03-01 · Grant · Acquired 14,400 · Balance 14,400 F2: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
F2: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2024 Filed Mar 5, 2024 23:20 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 28,800 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001415889-24-006843 · form4-03052024_110310.xml · derivative · entry 5 McKune John · CIK 0001650427 · INTERIM CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,800 Underlying: Common Stock · 28,800 shares Expires 2034-02-28 F6 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:20 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 14,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006843 · form4-03052024_110310.xml · nonDerivative · entry 4 McKune John · CIK 0001650427 · INTERIM CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,810 F5 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:20 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 669 | $9.06 | $6,061.14 |
DisclosureSEC source: 0001415889-24-006843 · form4-03052024_110310.xml · nonDerivative · entry 3 McKune John · CIK 0001650427 · INTERIM CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,410 F4 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:20 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 254 | $9.06 | $2,301.24 |
DisclosureSEC source: 0001415889-24-006843 · form4-03052024_110310.xml · nonDerivative · entry 2 McKune John · CIK 0001650427 · INTERIM CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,079 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:20 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 155 | $9.06 | $1,404.30 |
DisclosureSEC source: 0001415889-24-006843 · form4-03052024_110310.xml · nonDerivative · entry 1 McKune John · CIK 0001650427 · INTERIM CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,333 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. F2 · balance_after: Includes 841 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2024. Read SEC document |
| March 01, 2024 Filed Mar 8, 2024 00:57 UTC Amendment | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 14,400 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001415889-24-007232 · form4a-03082024_120350.xml · derivative · entry 2 McKune John · CIK 0001650427 · INTERIM CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,400 Underlying: Common Stock · 14,400 shares Expires 2034-02-28 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 8, 2024 00:57 UTC Amendment | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 28,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007232 · form4a-03082024_120350.xml · nonDerivative · entry 1 McKune John · CIK 0001650427 · INTERIM CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,210 F1 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:44 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 7,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057510 · doc4.xml · nonDerivative · entry 4 McKune John · CIK 0001650427 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,647 F4 · shares: Represents grant of the RSUs payable solely in common stock of the Issuer that will become fully vested on December 1, 2024. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:44 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 585 | $10.34 | $6,048.90 |
DisclosureSEC source: 0001209191-23-057510 · doc4.xml · nonDerivative · entry 3 McKune John · CIK 0001650427 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,414 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:44 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 222 | $10.34 | $2,295.48 |
DisclosureSEC source: 0001209191-23-057510 · doc4.xml · nonDerivative · entry 2 McKune John · CIK 0001650427 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,999 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:44 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 135 | $10.33 | $1,394.55 |
DisclosureSEC source: 0001209191-23-057510 · doc4.xml · nonDerivative · entry 1 McKune John · CIK 0001650427 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,221 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.